Comment on a Paper by Dupoiron Et Al. “A Phase III Randomized Controlled Study on the Efficacy and Improved Bowel Function of Prolonged-Release (PR) Oxycodone- Naloxone (Up to 160/80 Mg Daily) Versus Oxycodone PR”
European Journal of Pain - United States
doi 10.1002/ejp.1098
Full Text
Open PDFAbstract
Available in full text
Date
October 9, 2017
Authors
Publisher
Wiley